Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital

被引:3
|
作者
Li, Qiu-Yan [1 ]
Liu, Bin [2 ]
Liu, Lei [3 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Harbin, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 4, Dept Resp Med, Harbin, Peoples R China
关键词
antibiotic stewardship; antimicrobial resistance; antimicrobial susceptibility; infection control; Pseudomonas aeruginosa; BLOOD-STREAM INFECTION; ANTIMICROBIAL RESISTANCE; SURVEILLANCE; EPIDEMIOLOGY; PNEUMONIA;
D O I
10.1111/jcpt.13446
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and Objective The purpose of this study was to investigate the effect of imposing infection control programmes (ICPs) and antimicrobial stewardship (AMS) by monitoring the antimicrobial resistance of Pseudomonas aeruginosa. Methods Antimicrobial susceptibility testing was performed in accordance with the Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines. ICPs and AMS were initiated at the Fourth Hospital from 2013 to 2018. Results and discussion A total of 2,886 P. aeruginosa isolates were assessed. The antimicrobial resistance trends of the P. aeruginosa strains improved after the intervention measures. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa contributed to 18.5% and 3.5% of the total P. aeruginosa strains, respectively. Colistin was the most effective antibiotic against 97.6% of XDR-P. aeruginosa and 99.41% of MDR-P. aeruginosa. The consumption of alcohol-based hand gel (ABHG) increased from 0.6 L to 10.8 L per 1,000 patient-days (PD) (p = 0.005). The yearly consumption of antibiotics decreased from 45 to 37.5 defined daily doses (DDD) per 1,000 PD(p = 0.04). After 2013, the incidence rate of MDR-P. aeruginosa showed a significant decrease from 22% to 14.1% (p = 0.04), and XDR-P. aeruginosa decreased from 5.8% to 0.9%. The use of ABHG was negatively related to MDR-P. aeruginosa morbidity (r = -0.86; p = 0.021). The consumption of antibiotics was positively related to MDR-P. aeruginosa morbidity (r = 0.86; p = 0.021). What is new and Conclusion Successful control of MDR-P. aeruginosa resistance was achieved by imposing comprehensive ICPs and AMS.
引用
收藏
页码:1357 / 1366
页数:10
相关论文
共 50 条
  • [41] RISK FACTORS AND OUTCOMES OF HOSPITAL ACQUIRED PNEUMONIA CAUSED BY MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA
    Feng, Ding Yun
    Zou, Xiaoling
    Yang, Hailing
    Li, Wenjuan
    Zhou, Yuqi
    Zhang, Tiantuo
    RESPIROLOGY, 2017, 22 : 270 - 271
  • [42] Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection
    Le Guern, Remi
    Grandjean, Teddy
    Stabler, Sarah
    Bauduin, Marvin
    Gosset, Philippe
    Kipnis, Eric
    Dessein, Rodrigue
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [43] Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection
    Rémi Le Guern
    Teddy Grandjean
    Sarah Stabler
    Marvin Bauduin
    Philippe Gosset
    Éric Kipnis
    Rodrigue Dessein
    Nature Communications, 14
  • [44] Multidrug-resistant bacteria infection control: Study of compliance with isolation precautions in a Paris University hospital
    Vidal-Trecan, GM
    Delamare, N
    Tcherny-Lessenot, S
    Lamory, J
    Baudin, F
    de Prittwitz, M
    Salmon-Ceron, D
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (02): : 109 - 111
  • [45] Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing
    Holger, Dana J.
    Lev, Katherine L.
    Kebriaei, Razieh
    Morrisette, Taylor
    Shah, Rahi
    Alexander, Jose
    Lehman, Susan M.
    Rybak, Michael J.
    JOURNAL OF APPLIED MICROBIOLOGY, 2022, 133 (03) : 1636 - 1649
  • [46] MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTION IN PEDIATRIC PATIENTS RECEIVING CHEMOTHERAPY OR UNDERGOING HSCT
    Caselli, D.
    Cesaro, S.
    Zuno, O.
    Zanazzo, C.
    Manicone, R.
    Livadiotti, S.
    Cellini, M.
    Frenos, S.
    Milano, G. M.
    Capelli, B.
    Licciardello, M.
    Beretta, C.
    Arico, M.
    Castagnola, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S83 - S83
  • [47] IN VITRO ANTIBIOTIC SYNERGY ON MULTIDRUG-RESISTANT STRAINS OF PSEUDOMONAS AERUGINOSA ISOLATED FROM ONCOHAEMATOLOGICAL PATIENTS
    Lobreglio, G.
    D'Aversa, P.
    Malagnino, M.
    Leo, L.
    Monteduro, M. J.
    Russo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 416 - 417
  • [48] Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study
    M. Montero
    M. Sala
    M. Riu
    F. Belvis
    M. Salvado
    S. Grau
    J. P. Horcajada
    F. Alvarez-Lerma
    R. Terradas
    M. Orozco-Levi
    X. Castells
    H. Knobel
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 335 - 339
  • [49] Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection
    Domenig, C
    Traunmüller, F
    Kozek, S
    Wisser, W
    Klepetko, W
    Steininger, R
    Spiss, C
    Thalhammer, F
    TRANSPLANTATION, 2001, 71 (06) : 744 - 745
  • [50] Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm
    Adnan, Muhammad
    Shah, Muhammad Rahman Ali
    Jamal, Muhsin
    Jalil, Fazal
    Andleeb, Saadia
    Nawaz, Muhammad Asif
    Pervez, Sidra
    Hussain, Tahir
    Shah, Ismail
    Imran, Muhammad
    Kamil, Atif
    BIOLOGICALS, 2020, 63 : 89 - 96